{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T18:50:25Z","timestamp":1791399025860,"version":"4.3.3"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100023452","name":"Hanarth Fonds","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023452","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>The application of artificial intelligence (AI) to prostate MRI for clinically significant prostate cancer (csPCa) detection is an active area of medical imaging research. Yet, methodological deficiencies can undermine the reliability and clinical translatability of many published studies. This perspective provides a structured critical appraisal of AI studies in prostate MRI, organised around six evaluation domains: (i) limits of predictability, (ii) reference standard quality, (iii) cohort design and population selection (including spectrum and pathway biases), (iv) benchmark and comparator validity, (v) clinical deployment, and (vi) AI terminology. We illustrate each domain using recently published studies as representative examples, and we ground our perspective in the formal requirements recently established by the PI-RADS Steering Committee for AI development and reporting in biopsy-naive men. Our analysis suggests that apparent near-perfect performance can arise from identifiable and preventable study design choices rather than from technical advancements. Methodological shortcomings may be mistaken for genuine advances; ensuring that the evidence base meets these standards is a prerequisite for population-general utility.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Key Points<\/jats:title>\n                    <jats:p>\n                      <jats:bold>\n                        <jats:italic>Question<\/jats:italic>\n                      <\/jats:bold>\n                      <jats:italic>Can the reported near-perfect AI performance for prostate cancer detection on MRI be attributed to study design choices instead of technical advances?<\/jats:italic>\n                    <\/jats:p>\n                    <jats:p>\n                      <jats:bold>\n                        <jats:italic>Findings<\/jats:italic>\n                      <\/jats:bold>\n                      <jats:italic>Apparent near-perfect diagnostic accuracy can arise from identifiable study design choices, including spectrum bias, pathway bias, imperfect reference standards, and confounded comparisons<\/jats:italic>\n                      .\n                    <\/jats:p>\n                    <jats:p>\n                      <jats:bold>\n                        <jats:italic>Clinical relevance<\/jats:italic>\n                      <\/jats:bold>\n                      <jats:italic>Adopting structured appraisal criteria aligned with PI-RADS Committee requirements helps clinicians distinguish methodologically sound AI tools from those whose reported performance may not generalise to routine clinical populations<\/jats:italic>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00330-026-12915-8","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T17:59:14Z","timestamp":1791395954000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Critical appraisal of artificial intelligence studies for prostate cancer detection on MRI"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4661-9920","authenticated-orcid":false,"given":"Eduardo","family":"Pooch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Agrotis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivo G.","family":"Schoots","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Emberton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veeru","family":"Kasivisvanathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yipeng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,7]]},"reference":[{"key":"12915_CR1","doi-asserted-by":"crossref","unstructured":"Shao L, Liang C, Yan Y et al (2025) An MRI\u2013pathology foundation model for noninvasive diagnosis and grading of prostate cancer. Nat Cancer 6:1621\u20131637","DOI":"10.1038\/s43018-025-01041-x"},{"key":"12915_CR2","doi-asserted-by":"crossref","unstructured":"Wu H, Liu F, Yang Q et al (2025) Automated MRI system for clinically significant prostate cancer detection development validation and real-world implementation. Nat Commun 16:11583","DOI":"10.1038\/s41467-025-66593-z"},{"key":"12915_CR3","doi-asserted-by":"crossref","unstructured":"Rosenthal JT, Sabuncu MR (2025) Artificial intelligence and the limits of predictability in medicine. J Med Artif Intell 9:29","DOI":"10.21037\/jmai-2025-92"},{"key":"12915_CR4","doi-asserted-by":"crossref","unstructured":"Turkbey B, Huisman H, Fedorov A et al (2025) Requirements for AI development and reporting for MRI prostate cancer detection in biopsy-na\u00efve men: PI-RADS Steering Committee, version 1.0. Radiology 315:e240140","DOI":"10.1148\/radiol.240140"},{"key":"12915_CR5","doi-asserted-by":"publisher","first-page":"e200029","DOI":"10.1148\/ryai.2020200029","volume":"2","author":"J Mongan","year":"2020","unstructured":"Mongan J, Moy L, Kahn CE (2020) Checklist for artificial intelligence in medical imaging (CLAIM): a guide for authors and reviewers. Radiol Artif Intell 2:e200029","journal-title":"Radiol Artif Intell"},{"key":"12915_CR6","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-078378","volume":"385","author":"GS Collins","year":"2024","unstructured":"Collins GS, Moons KG, Dhiman P et al (2024) TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods. BMJ 385:e078378","journal-title":"BMJ"},{"key":"12915_CR7","doi-asserted-by":"publisher","unstructured":"Andrade MA, Rodrigues H, Colhado CH et al (2026) Artificial-intelligence models vs. radiologists in the detection of clinically significant prostate cancer on mpMRI: a meta-analysis. Eur Radiol. https:\/\/doi.org\/10.1007\/s00330-026-12465-z","DOI":"10.1007\/s00330-026-12465-z"},{"key":"12915_CR8","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1214\/088342306000000033","volume":"21","author":"RC Holte","year":"2006","unstructured":"Holte RC (2006) Elaboration on two points raised in \u201cClassifier technology and the illusion of progress\u201d. Stat Sci 21:24\u201326. https:\/\/doi.org\/10.1214\/088342306000000033","journal-title":"Stat Sci"},{"key":"12915_CR9","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/S0140-6736(16)32401-1","volume":"389","author":"HU Ahmed","year":"2017","unstructured":"Ahmed HU, El-Shater Bosaily A, Brown LC et al (2017) Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study. Lancet 389:815\u2013822","journal-title":"Lancet"},{"key":"12915_CR10","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1056\/NEJMoa1801993","volume":"378","author":"V Kasivisvanathan","year":"2018","unstructured":"Kasivisvanathan V, Rannikko AS, Borghi M et al (2018) MRI-targeted or standard biopsy for prostate-cancer diagnosis (PRECISION). N Engl J Med 378:1767\u20131777","journal-title":"N Engl J Med"},{"key":"12915_CR11","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1038\/s41391-020-00298-w","volume":"24","author":"E Bass","year":"2021","unstructured":"Bass E, Pantovic A, Connor M et al (2021) A systematic review and meta-analysis of the diagnostic accuracy of biparametric prostate MRI for prostate cancer in men at risk. Prostate Cancer Prostatic Dis 24:596\u2013611","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"12915_CR12","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.euo.2019.08.001","volume":"3","author":"S Goel","year":"2020","unstructured":"Goel S, Shoag JE, Gross MD et al (2020) Concordance between biopsy and radical prostatectomy pathology in the era of targeted biopsy: a systematic review and meta-analysis. Eur Urol Oncol 3:10\u201320. https:\/\/doi.org\/10.1016\/j.euo.2019.08.001","journal-title":"Eur Urol Oncol"},{"key":"12915_CR13","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/s41391-023-00714-x","volume":"27","author":"MJ Hagens","year":"2024","unstructured":"Hagens MJ, Ribbert LLA, Jager A et al (2024) Histopathological concordance between prostate biopsies and radical prostatectomy specimens-implications of transrectal and transperineal biopsy approaches. Prostate Cancer Prostatic Dis 27:312\u2013317. https:\/\/doi.org\/10.1038\/s41391-023-00714-x","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"12915_CR14","doi-asserted-by":"publisher","first-page":"4915","DOI":"10.1007\/s00330-024-11323-0","volume":"35","author":"F Giganti","year":"2025","unstructured":"Giganti F, Moreira da Silva N, Yeung M et al (2025) AI-powered prostate cancer detection: a multi-centre, multi-scanner validation study. Eur Radiol 35:4915\u20134924","journal-title":"Eur Radiol"},{"key":"12915_CR15","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/S1470-2045(24)00220-1","volume":"25","author":"A Saha","year":"2024","unstructured":"Saha A, Bosma JS, Twilt JJ et al (2024) Artificial intelligence and radiologists in prostate cancer detection on MRI (PICAI): an international, paired, non-inferiority, confirmatory study. Lancet Oncol 25:879\u2013887","journal-title":"Lancet Oncol"},{"key":"12915_CR16","doi-asserted-by":"crossref","unstructured":"Singh D, Carvalho AL, Mosquera I et al (2025) Monitoring of prostate cancer screening in the European Union: development of key performance indicators through the PRAISE-U project. EClinicalMedicine 80:103022","DOI":"10.1016\/j.eclinm.2024.103022"},{"key":"12915_CR17","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1093\/ehjdh\/ztab061","volume":"2","author":"AS Tseng","year":"2021","unstructured":"Tseng AS, Shelly-Cohen M, Attia IZ et al (2021) Spectrum bias in algorithms derived by artificial intelligence: a case study in detecting aortic stenosis using electrocardiograms. Eur Heart J Digit Health 2:561\u2013567","journal-title":"Eur Heart J Digit Health"},{"key":"12915_CR18","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1001\/jamaoncol.2024.5497","volume":"11","author":"CA Hamm","year":"2025","unstructured":"Hamm CA, Asbach P, P\u00f6hlmann A et al (2025) Oncological safety of MRI-informed biopsy decision-making in men with suspected prostate cancer. JAMA Oncol 11:145\u2013153","journal-title":"JAMA Oncol"},{"key":"12915_CR19","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1056\/NEJMoa1801993","volume":"378","author":"V Kasivisvanathan","year":"2018","unstructured":"Kasivisvanathan V, Rannikko AS, Borghi M et al (2018) MRI-targeted or standard biopsy for prostate-cancer diagnosis. N Engl J Med 378:1767\u20131777","journal-title":"N Engl J Med"},{"key":"12915_CR20","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/S1470-2045(18)30569-2","volume":"20","author":"O Rouvi\u00e8re","year":"2019","unstructured":"Rouvi\u00e8re O, Puech P, Renard-Penna R et al (2019) MRI-FIRST investigators. Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study. Lancet Oncol 20:100\u2013109. https:\/\/doi.org\/10.1016\/S1470-2045(18)30569-2","journal-title":"Lancet Oncol"},{"key":"12915_CR21","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.eururo.2019.05.029","volume":"76","author":"M van der Leest","year":"2019","unstructured":"van der Leest M, Isra\u00ebl B, Cornel EB et al (2019) High diagnostic performance of short magnetic resonance imaging protocols for prostate cancer detection in biopsy-na\u00efve men: the next step in magnetic resonance imaging accessibility. Eur Urol 76:574\u2013581. https:\/\/doi.org\/10.1016\/j.eururo.2019.05.029","journal-title":"Eur Urol"},{"key":"12915_CR22","doi-asserted-by":"crossref","unstructured":"Palsdottir T, Micoli C, Eklund M et al (2026) Stockholm3\u2013magnetic resonance imaging population-based prostate cancer screening study: two-year follow-up. Ann Intern Med 179:7","DOI":"10.7326\/ANNALS-25-04753-PS"},{"key":"12915_CR23","doi-asserted-by":"publisher","first-page":"e000057","DOI":"10.1136\/bmjonc-2023-000057","volume":"2","author":"CM Moore","year":"2023","unstructured":"Moore CM, Frangou E, McCartan N et al (2023) Prevalence of MRI lesions in men responding to a GP-led invitation for a prostate health check: a prospective cohort study. BMJ Oncol 2:e000057","journal-title":"BMJ Oncol"},{"key":"12915_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-99795-y","volume":"15","author":"NM Rodrigues","year":"2025","unstructured":"Rodrigues NM, de Almeida JG, Verde ASC et al (2025) Effective reduction of unnecessary biopsies through a deep-learning-assisted aggressive prostate cancer detector. Sci Rep 15:15211","journal-title":"Sci Rep"},{"key":"12915_CR25","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1162\/089976602753284446","volume":"14","author":"M Saerens","year":"2002","unstructured":"Saerens M, Latinne P, Decaestecker C (2002) Adjusting the outputs of a classifier to new a priori probabilities: a simple procedure. Neural Comput 14:21\u201341","journal-title":"Neural Comput"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-026-12915-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-026-12915-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-026-12915-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T17:59:16Z","timestamp":1791395956000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-026-12915-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,7]]},"references-count":25,"alternative-id":["12915"],"URL":"https:\/\/doi.org\/10.1007\/s00330-026-12915-8","relation":{},"ISSN":["1432-1084"],"issn-type":[{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,7]]},"assertion":[{"value":"12 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The scientific guarantor of this publication is Ivo Schoots.","order":1,"name":"Ethics","label":"Guarantor","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"G.A. is a member of the scientific editorial board of European Radiology and, as such, did not participate in the selection or review processes for this article. The remaining authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.","order":2,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Statistics and biometry","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Written informed consent was not required for this study because we used publicly available datasets.","order":4,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Institutional Review Board approval was not required because we used publicly available datasets.","order":5,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"N\/a.","order":6,"name":"Ethics","label":"Study subjects or cohorts overlap","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"order":7,"name":"Ethics","label":"Methodology","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}}]}}